Where it is registered
Each register with its number of medicines and a few of them.
Canada
Health Canada · 3 medicines
- Boostrix-Polio2.5 LF / 0.5 ML + 8 MCG / 0.5 ML + 40 D / 0.5 ML + 8 D / 0.5 ML + 32 D / 0.5 ML + 2.5 MCG / 0.5 ML + 8 MCG / 0.5 ML + 5.0 LF / 0.5 ML · Suspension · Glaxosmithkline INC
- Infanrix-Ipv/Hib30 UNIT / 0.5 ML + 25 MCG / 0.5 ML + 10 MCG / 0.5 ML + 40 UNIT / 0.5 ML + 8 UNIT / 0.5 ML + 32 UNIT / 0.5 ML + 8 MCG / 0.5 ML + 25 MCG / 0.5 ML + 40 UNIT / 0.5 ML · Suspension · Glaxosmithkline INC
- Infanrix-Ipv30 UNIT / 0.5 ML + 25 MCG / 0.5 ML + 40 UNIT / 0.5 ML + 8 UNIT / 0.5 ML + 32 UNIT / 0.5 ML + 8 MCG / 0.5 ML + 25 MCG / 0.5 ML + 40 UNIT / 0.5 ML · Suspension · Glaxosmithkline INC
All medicines with Inactivated poliovirus type i
Every register, a page at a time. Strengths and packs are on each medicine’s page.
8 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Boostrix-PolioCombination | Canada | 2.5 LF / 0.5 ML + 8 MCG / 0.5 ML + 40 D / 0.5 ML + 8 D / 0.5 ML + 32 D / 0.5 ML + 2.5 MCG / 0.5 ML + 8 MCG / 0.5 ML + 5.0 LF / 0.5 ML | Suspension | Marketed | Glaxosmithkline INC |
| Infanrix-Ipv/HibCombination | Canada | 30 UNIT / 0.5 ML + 25 MCG / 0.5 ML + 10 MCG / 0.5 ML + 40 UNIT / 0.5 ML + 8 UNIT / 0.5 ML + 32 UNIT / 0.5 ML + 8 MCG / 0.5 ML + 25 MCG / 0.5 ML + 40 UNIT / 0.5 ML | Suspension | Marketed | Glaxosmithkline INC |
| Infanrix-IpvCombination | Canada | 30 UNIT / 0.5 ML + 25 MCG / 0.5 ML + 40 UNIT / 0.5 ML + 8 UNIT / 0.5 ML + 32 UNIT / 0.5 ML + 8 MCG / 0.5 ML + 25 MCG / 0.5 ML + 40 UNIT / 0.5 ML | Suspension | Cancelled | Glaxosmithkline INC |
| Imovax PolioCombination | Canada | 29 UNIT / 0.5 ML + 7 UNIT / 0.5 ML + 26 UNIT / 0.5 ML | Solution | Marketed | Sanofi Vaccines Canada LTD. |
| Adacel-PolioCombination | Canada | 2 LF / 0.5 ML + 5 MCG / 0.5 ML + 5 MCG / 0.5 ML + 3 MCG / 0.5 ML + 2.5 MCG / 0.5 ML + 29 UNIT / 0.5 ML + 7 UNIT / 0.5 ML + 26 UNIT / 0.5 ML + 5 LF / 0.5 ML | Suspension | Marketed | Sanofi Vaccines Canada LTD. |
| Infanrix HexaCombination | Canada | 25 LF / 0.5 ML + 25 MCG / 0.5 ML + 10 MCG / 0.5 ML + 10 MCG / 0.5 ML + 8 MCG / 0.5 ML + 25 MCG / 0.5 ML + 40 UNIT / 0.5 ML + 8 UNIT / 0.5 ML + 32 UNIT / 0.5 ML + 10 LF / 0.5 ML + 40 MCG / 0.5 ML | Suspension | Marketed | Glaxosmithkline INC |
| PentacelCombination | Canada | 15 LF / 0.5 ML + 20 MCG / 0.5 ML + 5 MCG / 0.5 ML + 10 MCG / 0.5 ML + 3 MCG / 0.5 ML + 20 MCG / 0.5 ML + 29 UNIT / 0.5 ML + 7 UNIT / 0.5 ML + 26 UNIT / 0.5 ML + 30 MCG / 0.5 ML + 5 LF / 0.5 ML | Suspension | Marketed | Sanofi Vaccines Canada LTD. |
| QuadracelCombination | Canada | 15 LF / 0.5 ML + 20 MCG / 0.5 ML + 5 MCG / 0.5 ML + 3 MCG / 0.5 ML + 20 MCG / 0.5 ML + 29 UNIT / 0.5 ML + 7 UNIT / 0.5 ML + 26 UNIT / 0.5 ML + 5 LF / 0.5 ML | Suspension | Marketed | Sanofi Vaccines Canada LTD. |
At a glance
- Registers
- 1
- Medicines
- 3
- Companies
- 1